Stemline Therapeutics, Inc. (NASDAQ:STML) Moving Today - Up by 29.38%

Stemline Therapeutics, Inc. (NASDAQ:STML) Moving Today - Up by 29.38%”

Stemline Therapeutic (NASDAQ:STML)'s trailing twelve month revenues are $1.2 Million, whereas its price to sales ratio for the same period is 274.93. Stemline Therapeutics has a one year low of $5.50 and a one year high of $14.60.

Stemline Therapeutics, Inc. had its "buy" rating reiterated by analysts at H.C. Wainwright. The stock grabbed 9 new institutional investments totaling 293,895 shares while 15 institutional investors sold out their entire positions totaling 2,238,882 shares.

For the Current Quarter, the growth estimate for Stemline Therapeutics, -8.9%, while for the Next Quarter the stock growth estimate is -12.5%.

To gain some better insight into how Stemline Therapeutics, Inc.

QuinStreet, Inc. (NASDAQ:QNST)'s stock has performed at 96.01%.

Recently stock market analysts have updated their consensus ratings on shares of Stemline Therapeutics, Inc.

Many analysts have provided their estimated foresights on Stemline Therapeutics, Inc. Nationwide Fund Advisors now owns 11,900 shares of the biopharmaceutical company's stock worth $102,000 after purchasing an additional 858 shares during the last quarter.

Insider trading over the last 12 months, however, paints a different picture. Furthermore on 11/13/13 Aegis Capital "Maintained" the stock to Buy at $70. Of those transactions, there were 508,053 shares of STML bought and 59,215 shares sold.

Stemline Therapeutic (NASDAQ:STML) shares traded 29.38% up during most recent session to reach at the closing price of $13.65. After this sale, 2,085,380 common shares of STML are directly owned by the insider, with total stake valued at $28,465,437.

The most recent non open market insider trade was completed by DOBMEIER ERIC on 06/19/2017, and was a acquisition of 10,000 shares with a final price of $0.

12/05/2016 - Stemline Therapeutics, Inc. had its "buy" rating reiterated by analysts at Jefferies. The original version of this report can be accessed at

According to Stemline Therapeutics, Inc.'s latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 48.57%. The third largest holder is Farallon Capital Management Llc, which now holds $12.21 million worth of this stock and that ownership represents almost 3.7% of its market capitalization.

There are 84 institutional holders with active positions, accounting for 12.28 million shares in total. The company's shares were given away at $8.16 per share worth to an income of some $19,111 on account of Hoberman Kenneth. Wells Fargo & Company MN now owns 13,647 shares of the biopharmaceutical company's stock worth $117,000 after purchasing an additional 500 shares in the last quarter.

Like this



02 November 2017
Georgia, Alabama top 2 in playoff rankings, Penn State 7th
The three other undefeated playoff-eligible teams are No. 9 Wisconsin (8-0), No. 10 Miami (7-0) and No. 18 Central Florida (7-0). Notre Dame is coming off a dismal 4-8 season past year that made many suspect coach Brian Kelly was not long for South Bend.

02 November 2017
Illinois' new "Silver Search" helps find missing people suffering from Alzheimer's
The "Silver Search" campaign launched on Wednesday, November 1st, which is the start of Alzheimer's Disease Awareness Month. IL law enforcement will now get new training on how they can help people find loved ones with dementia who go missing.

02 November 2017
Stock Trading Watch for Engold Mines Ltd (EGM.V)
The Firm owns and operates three global cruise brands: Royal Caribbean International, Celebrity Cruises and Azamara Club Cruises. The company reported $1.71 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.67 by $0.04.

02 November 2017
SuperSport & Sundowns players nominated for top African awards
Manchester United and Ivory Coast defender Eric Bailly makes the list alongside Chelsea and Nigeria wing-back Victor Moses. Nominees for other awards, including best national team, club and coach, will be announced later.

02 November 2017
A Woman Just Became Pregnant While ALREADY Pregnant
She thought that the embryo that was implanted in her had split naturally into twins. "I was very surprised". ABC News' chief medical contributor, Dr.

02 November 2017
Vikings are 'prepared' to activate QB Teddy Bridgewater
They have until November 8 to activate quarterback Teddy Bridgewater, who is on the PUP list and has been out since August, 2016. But that doesn't mean Bridgewater would start over Case Keenum , who is 4-2 as a starter.

02 November 2017
Heart Risks From Black Licorice
Pregnant women should also avoid eating black licorice, the National Center for Complementary and Integrative Health advises. It's reversible, though; potassium levels return to normal after you stop eating too much of it.

02 November 2017
U2 announces album of 'intimate letters'
Tickets go on sale Monday, November 20 at 10 a.m. exclusively through Ticketmaster's Verified Fan program . Those wanting to buy passes must register with the Ticketmaster Verified Fan page by November 18.

02 November 2017
Blueprint Medicines Corporation (NASDAQ:BPMC) Moving Today - Down by 3.08%
The Company focuses on crafting drug candidates that provide clinical responses to patients without adequate treatment options. Cowen and Company restated a "buy" rating on shares of Blueprint Medicines a research report on Tuesday, August 9th.

02 November 2017
Kemper Corporation (NYSE:KMPR) is Overbought Based on Its RSI
McQueen Ball & Associates Inc. bought a new stake in Kemper Corp. during the second quarter worth approximately $256,000. BidaskClub raised Kemper Corporation from a "buy" rating to a "strong-buy" rating in a report on Thursday, October 5th.